{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:30:15Z","timestamp":1793608215282,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100029643","name":"Collaboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029643","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.josat.2026.209942","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:27:12Z","timestamp":1773458832000},"page":"209942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Perspectives from opioid treatment program staff on community pharmacy-based methadone dispensing in North Carolina"],"prefix":"10.1016","volume":"186","author":[{"given":"Caroline","family":"Shubel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Marley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayla","family":"Ostrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delesha","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.209942_bb0005","series-title":"Increasing the number of OTPs and patients in the United States","author":"AATOD","year":"2022"},{"key":"10.1016\/j.josat.2026.209942_bb0010","series-title":"The Modernizing Opioid Treatment Access (MOTA) act: Fact-checking sheet","author":"AATOD","year":"2023"},{"issue":"6","key":"10.1016\/j.josat.2026.209942_bb0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/00952990.2021.1979991","article-title":"The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era","volume":"47","author":"Amram","year":"2021","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2026.209942_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108486","article-title":"A systematic review of stigma interventions for providers who treat patients with substance use disorders","volume":"131","author":"Bielenberg","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209942_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2023.100138","article-title":"Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone","volume":"6","author":"Carl","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"1","key":"10.1016\/j.josat.2026.209942_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/ADM.0000000000001244","article-title":"A brief online training to address pharmacists\u2019 willingness to dispense buprenorphine","volume":"18","author":"Carpenter","year":"2024","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.209942_bb3005","series-title":"Community Pharmacist Perspectives on Methadone Services: A Cross-Sectional Survey Study","author":"Carpenter","year":"2026"},{"key":"10.1016\/j.josat.2026.209942_bb0035","article-title":"Opioid agonist treatment and trust in the community pharmacy setting: A qualitative study of perceptions and experiences","author":"Caruana","year":"2024","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"4","key":"10.1016\/j.josat.2026.209942_bb0040","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/dar.12032","article-title":"Factors influencing pharmacy services in opioid substitution treatment","volume":"32","author":"Chaar","year":"2013","journal-title":"Drug and Alcohol Review"},{"issue":"25","key":"10.1016\/j.josat.2026.209942_bb0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: Population estimates \u2014 United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1016\/j.josat.2026.209942_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/jrh.12264","article-title":"Perceived barriers and facilitators to providing methadone maintenance treatment among rural community pharmacists in southwestern Ontario","volume":"34","author":"Fonseca","year":"2018","journal-title":"The Journal of Rural Health"},{"issue":"1","key":"10.1016\/j.josat.2026.209942_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","article-title":"\"It\u2019s like \u201cliquid handcuffs\": The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients\u2019 lives\u201d","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduction Journal"},{"issue":"5","key":"10.1016\/j.josat.2026.209942_bb0060","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.sapharm.2020.06.024","article-title":"Methods and strategies for effectively surveying the LGBTQ+ population","volume":"17","author":"Hughes","year":"2021","journal-title":"Research in Social & Administrative Pharmacy"},{"issue":"2","key":"10.1016\/j.josat.2026.209942_bb0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/10550887.2023.2165869","article-title":"Geographic variation in availability of opioid treatment programs across U.S. communities","volume":"42","author":"Jehan","year":"2024","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.josat.2026.209942_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108219","article-title":"Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19","volume":"122","author":"Joseph","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209942_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107968","article-title":"Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study","volume":"211","author":"Joudrey","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2026.209942_bb0080","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamapsychiatry.2020.1624","article-title":"Comparison of driving times to opioid treatment programs and pharmacies in the US","volume":"77","author":"Kleinman","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.josat.2026.209942_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5055\/jom.2021.0645","article-title":"Patient satisfaction with clinic-based medication pick up: Addressing pharmacy-level challenges to buprenorphine access","volume":"17","author":"Kolb","year":"2021","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.josat.2026.209942_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019","volume":"110","author":"Krawczyk","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2026.209942_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/29767342231215178","article-title":"Relationships between stigma, risk tolerance, and buprenorphine dispensing intentions among community-based pharmacists: Results From a national sample","volume":"45","author":"Light","year":"2024","journal-title":"Substance Use & Addiction Journal"},{"issue":"1","key":"10.1016\/j.josat.2026.209942_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","article-title":"The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review","volume":"107","author":"Livingston","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.209942_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209235","article-title":"Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic","volume":"157","author":"L\u00f3pez-Castro","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"3","key":"10.1016\/j.josat.2026.209942_bb0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0955-3959(00)00047-5","article-title":"Involvement of community pharmacists in the care of drug misusers: Pharmacy-based supervision of methadone consumption","volume":"11","author":"Luger","year":"2000","journal-title":"The International Journal on Drug Policy"},{"issue":"12","key":"10.1016\/j.josat.2026.209942_bb0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/pb.bp.109.028951","article-title":"Stigmatised attitudes in independent pharmacies associated with discrimination towards individuals with opioid dependence","volume":"34","author":"Luty","year":"2010","journal-title":"The Psychiatrist"},{"issue":"2","key":"10.1016\/j.josat.2026.209942_bb0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/ACM.0000000000005467","article-title":"Stigma against patients with substance use disorders among health care professionals and trainees and stigma-reducing interventions: A systematic review","volume":"99","author":"Magnan","year":"2024","journal-title":"Academic Medicine"},{"key":"10.1016\/j.josat.2026.209942_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2022.100204","article-title":"Factors in rural community buprenorphine dispensing","volume":"9","author":"Major","year":"2023","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"10.1016\/j.josat.2026.209942_bb3010","series-title":"Barriers and Facilitators to Pharmacy-Based Methadone Dispensing: Semi-Structured Interviews with Pharmacists","author":"Marley","year":"2026"},{"key":"10.1016\/j.josat.2026.209942_bb3000","series-title":"Methadone in Community Pharmacies: A Mixed Methods Evaluation of Board-Certified Addiction Medicine Physicians and Addiction Psychiatrists Perspectives","author":"Marley","year":"2026"},{"key":"10.1016\/j.josat.2026.209942_bb0130","series-title":"S. 644, Congress","author":"Modernizing Opioid Treatment Access Act","year":"2023"},{"issue":"7","key":"10.1016\/j.josat.2026.209942_bb0135","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5055\/jom.2023.0784","article-title":"To expand pharmacy-based dispensing of methadone for OUD, reduce OTP medication unit burdens and delays","volume":"19","author":"Morse","year":"2023","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.josat.2026.209942_bb0140","author":"NCDHHS"},{"issue":"2","key":"10.1016\/j.josat.2026.209942_bb0145","article-title":"Methadone maintenance treatment as social control: Analyzing patient experiences","volume":"26","author":"O\u2019Byrne","year":"2019","journal-title":"Nursing Inquiry"},{"issue":"2","key":"10.1016\/j.josat.2026.209942_bb0150","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.japh.2021.10.002","article-title":"Ensuring buprenorphine access in rural community pharmacies to prevent overdoses","volume":"62","author":"Ostrach","year":"2022","journal-title":"Journal of the American Pharmaceutical Association (2003)"},{"key":"10.1016\/j.josat.2026.209942_bb0155","series-title":"\u201cMethadone at the pharmacy like Suboxone\u00ae?... It would untangle a lot of tangles.\u201d \u2013 Perspectives of North Carolinians with lived experience of opioid use on potential benefits of methadone dispensing at community pharmacies","author":"Ostrach","year":"2025"},{"key":"10.1016\/j.josat.2026.209942_bb0160","author":"Pew"},{"issue":"8","key":"10.1016\/j.josat.2026.209942_bb0165","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/add.16180","article-title":"Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety","volume":"118","author":"Saloner","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.209942_bb0170","author":"SAMHSA"},{"key":"10.1016\/j.josat.2026.209942_bb0175","author":"SAMHSA"},{"issue":"5","key":"10.1016\/j.josat.2026.209942_bb0180","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1360-0443.2011.03700.x","article-title":"Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings","volume":"107","author":"Schwartz","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.209942_bb0185","series-title":"Expanding methadone access through community pharmacies: Opioid treatment program staff perceptions of pharmacy-based medication units","author":"Shubel","year":"2025"},{"issue":"S2","key":"10.1016\/j.josat.2026.209942_bb0190","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.2105\/AJPH.2021.306665","article-title":"The methadone manifesto: Treatment experiences and policy recommendations from methadone patient activists","volume":"112","author":"Simon","year":"2022","journal-title":"American Journal of Public Health"},{"issue":"9","key":"10.1016\/j.josat.2026.209942_bb0195","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1377\/hlthaff.2025.00344","article-title":"Key-informant perspectives on pharmacy-based methadone treatment for opioid use disorder in The US","volume":"44","author":"Stewart","year":"2025","journal-title":"Health Aff (Millwood)."},{"key":"10.1016\/j.josat.2026.209942_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108031","article-title":"One year of methadone maintenance treatment in a fentanyl endemic area: Safety, repeated exposure, retention, and remission","volume":"115","author":"Stone","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209942_bb0205","series-title":"Federal guidelines for opioid treatment programs","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"10.1016\/j.josat.2026.209942_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2021.100082","article-title":"Rural community pharmacist willingness to dispense Suboxone\u00ae - A secret shopper investigation in South-Central Appalachia","volume":"4","author":"Trull","year":"2021","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"10.1016\/j.josat.2026.209942_bb0215","series-title":"2020 Rural-urban commuting area codes","author":"U.S. Department of Agriculture, Economic Research Service","year":"2025"},{"issue":"2","key":"10.1016\/j.josat.2026.209942_bb0220","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.josat.2026.209942_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implementation Science"},{"issue":"1","key":"10.1016\/j.josat.2026.209942_bb0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13722-023-00399-6","article-title":"Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: A qualitative study in the U.S","volume":"18","author":"Wu","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2026.209942_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13011-023-00563-w","article-title":"Pharmacy-based methadone treatment in the US: Views of pharmacists and opioid treatment program staff","volume":"18","author":"Wu","year":"2023","journal-title":"Substance Abuse Treatment, Prevention, and Policy"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:16:53Z","timestamp":1793607413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"alternative-id":["S2949875926000627"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.209942","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives from opioid treatment program staff on community pharmacy-based methadone dispensing in North Carolina","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.209942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209942"}}